CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2019)
CorMedix (CRMD) posted Amortizatization of Intangibles of $84000.0 for Q3 2019, down 26.67% sequentially from $114547.0 in Q2 2019.
CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2019) Analysis & Trends
CorMedix has reported Amortizatization of Intangibles for 3 years, with the latest figure at $84000.0 in Q3 2019.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $84000.0 in Q3 2019, while the trailing twelve-month figure through Dec 2019 was $313095.0 (changed N/A YoY) and the FY2019 annual result came in at $313097.0, down 75.38% from the prior year.
- Amortizatization of Intangibles declined to $84000.0 in Q3 2019 per CRMD's latest filing, from $114547.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $114548.0 in Q1 2019 and troughed at $84000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 84,000.00 |
| Sep 30, 2019 | 84,000.00 |
| Jun 30, 2019 | 114,547.00 |
| Jun 30, 2019 | 114,547.00 |
| Mar 31, 2019 | 114,548.00 |
| Mar 31, 2019 | 114,548.00 |
| Mar 31, 2013 | 328,761.00 |
| Mar 31, 2013 | 328,761.00 |
| Dec 31, 2012 | 259,846.00 |
| Dec 31, 2012 | 259,846.00 |